Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 2/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | CA2 | P00918 | 3/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | TYR | P14679 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.42 |
| ▸ | GLRB | P48167 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30123824 | 1.00 | HSPA5 (0.75) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL29558774 | 0.86 | HSPA5 (0.78) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL29351672 | 0.86 | HSPA5 (1.00) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL29415372 | 0.86 | HSPA5 (1.00) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL34162 | 0.86 | HSPA5 (1.00) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL2230912 | 0.86 | HSPA5 (0.78) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL17500063 | 0.85 | HSPA5 (0.70) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL1174207 | 0.85 | HSPA5 (0.55) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL11247674 | 0.84 | CYP2C9 (1.00) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A | |
| SCHEMBL29357108 | 0.84 | CYP2C9 (1.00) | HSPA5SMN1; SMN2CYP2C9CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115444917-B | Traditional Chinese medicine composition and traditional Chinese medicine cream for treating eczema, and preparation methods and application thereof | 新疆医科大学第四附属医院 | 2024-05-24 | — | — | CN | claimed |
| CN-115444917-A | Traditional Chinese medicine composition and traditional Chinese medicine cream for treating eczema as well as preparation method and application of traditional Chinese medicine cream | 新疆医科大学第四附属医院 | 2022-12-09 | — | — | CN | claimed |
| CN-108079349-B | Large-area factory building sterilization and disinfection device | 浙江泰林生物技术股份有限公司 | 2020-10-09 | — | — | CN | claimed |
| CN-115444917-B | Traditional Chinese medicine composition and traditional Chinese medicine cream for treating eczema, and preparation methods and application thereof | 新疆医科大学第四附属医院 | 2024-05-24 | — | — | CN | disclosed |
| US-20240026124-A1 | USE OF DIEUGENOL, OLIGOMERS AND/OR POLYMERS OF EUGENOL FOR STABILIZING ORGANIC MATERIALS, STABILIZED PLASTICS COMPOSITION, STABILIZER COMPOSITION AND METHOD FOR STABILIZING ORGANIC MATERIALS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-01-25 | — | — | US | disclosed |
| WO-2023108588-A1 | PROCESS FOR PRODUCING CABLE WITH INSULATION LAYER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023108586-A1 | OLEFIN/SILANE INTERPOLYMER COMPOSITIONS WITH EXCELLENT THERMAL OXIDATION RESISTANCE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-22 | — | — | WO | disclosed |
| CN-115444917-A | Traditional Chinese medicine composition and traditional Chinese medicine cream for treating eczema as well as preparation method and application of traditional Chinese medicine cream | 新疆医科大学第四附属医院 | 2022-12-09 | — | — | CN | disclosed |
| CN-108079349-B | Large-area factory building sterilization and disinfection device | 浙江泰林生物技术股份有限公司 | 2020-10-09 | — | — | CN | disclosed |
| US-10351771-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2019-07-16 | — | — | US | disclosed |
| CN-105142605-B | 1, 2-alkane polyol-containing composition | 大阪有机化学工业株式会社 | 2018-06-08 | — | — | CN | disclosed |
| US-8268381-B2 | Methods and systems for coating a medical device | ALLACCEM, INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-8067403-B2 | Methods and systems for preparing an antimicrobial composition | ALLACCEM, INC. (US) | 2011-11-29 | — | — | US | disclosed |
| US-20110124824-A1 | DISPERSION COMPOSITION, POLYMERIZABLE COMPOSITION, LIGHT-SHIELDING COLOR FILTER, SOLID-STATE IMAGE PICK-UP ELEMENT, LIQUID CRYSTAL DISPLAY DEVICE, WAFER LEVEL LENS, AND IMAGE PICK-UP UNIT | FUJIFILM CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
| US-20110015300-A1 | METHODS AND SYSTEMS FOR COATING A SURFACE | ALLACCEM, INC. | 2011-01-20 | — | — | US | disclosed |
| US-7713955-B2 | Applying to a surface one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning | ALLACCEM, INC. (US) | 2010-05-11 | — | — | US | disclosed |
| US-20100016270-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR CONTROLLING CHOLESTEROL LEVELS | ALLACCEM, INC. | 2010-01-21 | — | — | US | disclosed |
| US-20080207581-A1 | Applying to a surface one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning | ALLACCEM, INC. | 2008-08-28 | — | — | US | disclosed |
| US-20080020127-A1 | Methods and systems for coating a medical device | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016270-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR CONTROLLING CHOLESTEROL LEVELS | PCSK9, HMGCR, CETP | HSPA5 2151/4885SMN1; SMN2 1707/4885CYP2C9 274/4885 |
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | DNMT1, TET2, POLR1C | HSPA5 3123/4885SMN1; SMN2 1784/4885CYP2C9 3078/4885 |
| US-20080207581-A1 | Applying to a surface one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning | DNMT1, TET2, CD14 | HSPA5 3874/4885SMN1; SMN2 3889/4885CYP2C9 2484/4885 |
| US-20110015300-A1 | METHODS AND SYSTEMS FOR COATING A SURFACE | DNMT1, TET2, DNMT3A | HSPA5 3234/4885SMN1; SMN2 1791/4885CYP2C9 2746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.